Studies have shown that SCs can specifically activate receptor tyrosine kinase family members on the surface of tumor cells (including the RET, TrkA, TrkB) by secreting GDNF, NGF, and BDNF [449]. The gene discussed is NTRK1; the disease is neoplasm.